Citalopram hydrobromide got FDA approval in 1998 and is the most selective serotonin reuptake inhibitor.

**FDA-approved Indication**

- Citalopram hydrobromide is for the treatment of depression inÂ adults 18 years or older

- Recommendation: Adult, class IIa

- Strength of Evidence: Adult, category B

**Off-label Use**

- Obsessive-compulsive disorder (OCD)

- Panic disorder

- Generalized anxiety disorder (GAD)

- Social anxiety disorder (SAD)

- Separation anxiety disorder

- Premenstrual dysphoric disorder (PMDD)

- Binge eating disorder

- Post-traumatic stress disorder (PTSD)

The advantages and disadvantages of using this drug in non-FDA-approved conditions have their basis on the patient's condition and the clinician's judgment.